ENZ Financial Facts

Net loss: -1.47M
Provision for uncollectible accounts receivable: 669K
See Full Income Statement

Total stockholders’ equity: 88.49M
Accounts receivable, net of allowances: 14.06M
See Full Balance Sheet

Enzo Biochem (ENZ) Earnings

  |   Expand Research on ENZ
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +26.7% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +0.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
6/16/25 Q325 N/AN/A N/A N/AN/A N/A N/A N/A
3/17/25 Q225 -$0.02N/A N/A $7.3MN/A N/A Details
12/16/24 Q125 -$0.05N/A N/A $6.21MN/A N/A Details
12/13/24 Q125 N/AN/A N/A N/AN/A N/A N/A N/A
12/11/24 Q125 N/AN/A N/A N/AN/A N/A N/A N/A
10/28/24 Q424 N/AN/A N/A N/AN/A N/A N/A N/A
10/21/24 Q424 N/AN/A N/A N/AN/A N/A N/A N/A
10/15/24 Q424 N/AN/A N/A N/AN/A N/A N/A N/A